Clinical Trial Update: Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux. [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating chemoradiotherapy with docetaxel, cisplatin, 5-fluorouracil, and cetuximab for head and neck squamous cell carcinoma has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Adrucil (5-fluorouracil)
• ERBITUX (cetuximab)
• Platinol (cisplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: Groupe Oncologie Radiotherapie Tete et Cou | Conditions: Squamous Cell Head and Neck Carcinoma | Phase 3 | Status: COMPLETED